Arkadios Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $672K | Sell |
|
|||||
|
2025
Q2 | $516K | Sell |
|
|||||
|
2025
Q1 | $382K | Sell |
|
|||||
|
2024
Q4 | $479K | Buy |
|
|||||
|
2024
Q3 | $531K | Buy |
|
|||||
|
2024
Q2 | $582K | Sell |
|
|||||
|
2024
Q1 | $741K | Sell |
|
|||||
|
2023
Q4 | $690K | Sell |
|
|||||
|
2023
Q3 | $511K | Buy |
|
|||||
|
2023
Q2 | $625K | Sell |
|
|||||
|
2023
Q1 | $529K | Sell |
|
|||||
|
2022
Q4 | $477K | Sell |
|
|||||
|
2022
Q3 | $852K | Sell |
|
|||||
|
2022
Q2 | $805K | Buy |
|
|||||
|
2022
Q1 | $830K | Buy |
|
|||||
|
2021
Q4 | $971K | Buy |
|
|||||
|
2021
Q3 | $19K | Hold |
|
|||||
|
2021
Q2 | $27K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $5K | Buy |
|
|||||
|
2020
Q3 | $2.2K | Hold |
|
|||||
|
2020
Q2 | $1.82K | Hold |
|
|||||
|
2020
Q1 | $848 | Buy |
|